Proteomic Approach to Gastrointestinal Stromal Tumor Identified Prognostic Biomarkers

Daisuke Kubota^1,2, Akihiko Yoshida³, Kazutaka Kikuta⁴, Tsuyoshi Saito⁵, Yoshiyuki Suehara², Masahiro Gotoh⁶, Akira Kawai¹ and Tadashi Kondo^7*

¹Division of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan

²Department of Orthopedics, Juntendo University, Tokyo, Japan

³Department of Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan

⁴Department of Orthopedics, Tachikawa Memorial Hospital, Tokyo, Japan

⁵Department of Human Pathology, Juntendo University, Tokyo, Japan

⁶Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan

⁷Division of Pharmacoproteomics, National Cancer Center Research Institute, Tokyo, Japan

^*Corresponding Author: Tadashi Kondo, Chief, Division of Pharmacoproteomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104- 0045, Japan, Tel: +81-3-3542-2511 Exn. 3004, Fax: +81-3-3547-5298